4 hrs ago | MediLexicon
Chicago Area Nonprofit Fills Unique Niche For Low-Income Cancer Patients During Chemotherapy
Main Category: Health Insurance / Medical Insurance Also Included In: Cancer / Oncology Article Date: 19 Aug 2008 When the doctor told Dionne she had breast cancer, she was stunned.
13 hrs ago | The Times and Democrat
Correction: Prostate screenings story
In an Aug. 17 story about free prostate cancer screenings, The Associated Press reported erroneously the dates the screenings would take place and the name of the organization offering them.
For those with a personal stake in the health of the prostate gland, recent guidelines on cancer screenings bring a welcome measure of sanity to the question, "To test or not to test?" The guidelines issued ...
Spice-like Molecules May Help Fight Cancer
The researchers are combining organic chemistry, computer-aided design and molecular biology techniques in developing and testing pharmaceutical compounds that can fight breast and prostate cancer cells.
Current Publishing Hometown newspape...
New Web site helps fight prostate cancer
REGIONAL : A new Maine Web site dedicated to helping battle prostate cancer has been launched by the Maine Coalition to Fight Prostate Cancer .
Free cancer screenings today in MB
Facts about prostate cancer * Prostate cancer is the most common non-skin cancer in America, affecting one in six men.
The Influence Of Serial Prostate-Specific Antigen (PSA) Screening ...
Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology Article Date: 17 Aug 2008 - 0:00 PDT UroToday.com - The PSA test is now a widely used test for screening men for prostate cancer ...
Indevus Pharmaceuticals, Inc. Announces Issuance of U.S. Patent for Sanctura XR
Indevus Pharmaceuticals, Inc. announced today the issuance of U.S. Patent No. 7,410,978 , entitled "Once Daily Dosage Forms of Trospium," which is licensed exclusively to the Company by the patent's assignee, ...
Alternative Vaccine Strategy Shows Promise in Prostate Cancer Patients
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces ...
Antisoma PLC Says Evidence of Activity Seen in New Data from ASA404 Prostate Cancer Trial
Antisoma PLC Says Evidence of Activity Seen in New Data from ASA404 Prostate Cancer Trial 8/15/2008 London, UK, and Cambridge, MA, 15 August 2008 - Antisoma plc today announced survival data from its phase II ...
Athens: Desk jobs increase risk of prostate cancer
MEN who work sitting at a desk are more likely to develop prostate cancer than manual workers, a study has shown.
Bavarian Nordic Announces Partnership With National Cancer Institute...
Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology ; Cancer / Oncology ; Immune System / Vaccines Article Date: 13 Aug 2008 - 3:00 PDT Bavarian Nordic's US subsidiary, BN ...
Dendreon initiates another Provenge trial
Dendreon Corp. said it had started a new trial of its Provenge prostate cancer treatment in 120 men with advanced prostate cancer that does not respond to standard hormone therapy.
Vitamin D doesn't cut prostate cancer risk
Vitamin D -- the so-called sunshine vitamin -- does not appear to cut a man's risk of getting prostate cancer, researchers said on Tuesday.
VIDEO: Sound Off: Testing for Prostate Cancer
Sound Off: Testing for Prostate Cancer
Norwalk Hospital advances its technology with robot
NORWALKBy JILL BODACHHour Staff WriterThere is a new doctor at Norwalk Hospital, and his co-workers sure know how to push his buttons -- which is a good thing, since he's a robot.Norwalk Hospital recently ...
Eastern Pa. hospital to get cancer therapy center
An eastern Pennsylvania hospital will soon be offering a new high-tech cancer treatment therapy.
Surgery Helps With Prostate Cancer, Sometimes
The latest update from a European study that has followed men with prostate cancer for more than a decade leaves the debate about the advantages of aggressive treatment versus "watchful waiting" undecided.
New Screening Guidelines: Don't Test Men Over 75 For Prostate Cancer
Over the age of 75 years, men should no longer be screened for prostate cancer, according to recommendations from the U.S. Preventive Services Task Force published on August 5, 2008 in the Annals of Internal ...
Study: Prostate Cancer Treatment May Help Memory Loss
In the treatment, certain drugs deplete hormones, which in turn, slow the growth of cancer cells.